Three dividend-paying pharmaceutical investments to purchase amid the COVID-19 crisis avoid focusing solely on the top contenders for developing vaccines to protect against the dreaded novel coronavirus, since the share price of many of those stocks already have rocketed. However, an exchange-traded fund (ETF) offers exposure to promising vaccine makers as they pursue testing that may result in obtaining approval from the Food and Drug Administration (FDA) within months rather than years.
Bob Carlson, leader of the Retirement Watch investment newsletter, said he firmly recommends Bristol Myers Squibb (NYSE:BMY). He first advised buying the stock on June 29 and it since has risen $57.80 to $62.51, while also paying a $0.45 per share dividend on July 2. Bristol Myers Squibb’s trailing 12-month price-to-earnings (P/E) ratio is 10.87 times its earnings, compared to the Medical — Biomedical and Genetics industry’s ratio of 25.78 times earnings, according to Zacks. As a result, Bristol Myers Squibb trades at a big discount compared to its industry peers as it tries to absorb Celgene. Pfizer Inc (NYSE:PFE), a New York City-based multinational pharmaceutical company, offers a current dividend yield of 3.99% and trades at a P/E ratio of 14.99. That P/E ratio tops Bristol Myers Squibb’s P/E ratio but is much lower than the 25.78 times earnings of the Medical – Biomedical and Genetics industry.
Source: Dividend Investor
Related Articles:
Three Dividend-Paying Pharmaceutical Equities Offer Hope Amid COVID-19 Crisis
Posted by D4L | Tuesday, September 22, 2020 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
~
Popular Posts Last 30 Days
-
As a relatively new blogger, the one thing that has stood out in my mind is the number of Canadian bloggers in the areas that I am most inte...
-
In short, dividend-bearing stocks are one of the smartest approaches stock investors have available currently. The same is true in strong ec...
-
If your growth-investing days are over (or nearly so) and you're more interested in steady income, start your search with all-weather st...
-
Even in the current inflationary environment, where stocks across a wide variety of sectors are trading down, companies with a favorable his...
-
Finding cheap dividend stocks is critical for another reason. By the time the Federal Reserve meets for the second time in 2023, the central...
-
Investing in passive income can allow you to make money with minimal portfolio management. There are many types of investments to make passi...
-
Many companies make very predictable fixed dividend payments each quarter. When they do, their investors have a pretty good idea of how much...
-
As 2022 wraps up, many investors are likely looking for ways to position their portfolio for more macroeconomic uncertainty next year. After...
-
Linked here is a detailed quantitative analysis of Chevron Corporation (CVX). Below are some highlights from the above linked analysis: Comp...
-
Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) is crushing the market this year as value and dividend stocks have pulle...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.